abrdn Life Sciences Investors
HQL
46 hedge funds and large institutions have $40.7M invested in abrdn Life Sciences Investors in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 7 closing their positions.
18% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 17
6% more capital invested
Capital invested by funds: $38.3M → $40.7M (+$2.32M)
0.28% less ownership
Funds ownership: 11.52% → 11.24% (-0.28%)
8% less funds holding
Funds holding: 50 → 46 (-4)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$769K |
| 2 |
DA
Doliver Advisors
Houston,
Texas
|
+$491K |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$407K |
| 4 |
NIM
Needham Investment Management
New York
|
+$403K |
| 5 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$317K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Advisors Asset Management
Monument,
Colorado
|
-$880K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$692K |
| 3 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$532K |
| 4 |
Morgan Stanley
New York
|
-$291K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$287K |
HQL Hedge Fund Activity: Q3 2016 in Review
46 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2016, worth a combined $40.7M — up 6.1% from $38.3M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of HQL and 3 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 20 added.
The largest buyer was Citigroup, adding an estimated $769K. The largest seller was Advisors Asset Management, cutting an estimated $880K.
- 46 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2016, down from 50 in Q2 2016.
- Funds reported $40.7M of abrdn Life Sciences Investors stock for Q3 2016, up 6.1% quarter-over-quarter.
- 3 funds opened new abrdn Life Sciences Investors positions in Q3 2016 and 7 closed out, a net change of -4 holders.
- The largest abrdn Life Sciences Investors buyer in Q3 2016 was Citigroup, an estimated $769K added.
- The largest abrdn Life Sciences Investors seller in Q3 2016 was Advisors Asset Management, an estimated $880K sold.
Based on aggregated 13F filings for Q3 2016.